Back to Search
Start Over
Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation
- Source :
- Acta haematologica. 109(1)
- Publication Year :
- 2002
-
Abstract
- The treatment of immune-mediated hemolytic anemia (IHA) complicating hematopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T- and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody
- Subjects :
- Hemolytic anemia
medicine.medical_treatment
Mucopolysaccharidosis I
T-Lymphocytes
Antigens, CD19
chemical and pharmacologic phenomena
Hematopoietic stem cell transplantation
Lymphocyte Depletion
Immune Hemolytic Anemia
Mucopolysaccharidosis type I
Antibodies, Monoclonal, Murine-Derived
Hemoglobins
immune system diseases
hemic and lymphatic diseases
parasitic diseases
medicine
Humans
Transplantation, Homologous
Hurler syndrome
B-Lymphocytes
Transplantation Chimera
business.industry
Hematopoietic Stem Cell Transplantation
Antibodies, Monoclonal
Infant
Hematology
General Medicine
medicine.disease
Transplantation
surgical procedures, operative
Treatment Outcome
Immunology
Storage disease
Rituximab
Immune hemolytic anemia
Female
Anemia, Hemolytic, Autoimmune
Stem cell
business
medicine.drug
Subjects
Details
- ISSN :
- 00015792
- Volume :
- 109
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Acta haematologica
- Accession number :
- edsair.doi.dedup.....6af6ef02175d92b49fda0800a07b6c14